Concepedia
Statistics
Publications
9
Citations
1K
H-Index
Active since
1995
Affiliations
Vrije Universiteit Amsterdam(Current)
Freie Universität Berlin
Ottawa Hospital
Vall d'Hebron Hospital Universitari
Heinrich Heine University Düsseldorf
S. Dahms is an author at Vrije Universiteit Amsterdam specializing in neuroimmunology, microbiology, and life sciences.
Publications per year
1995–2007
Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study
Ludwig Kappos, Mark S. Freedman, Chris H. Polman et al. · The Lancet · 2007 · 501 citations
Life Sciences, Neurology, Neuroimmunology +9
Lack of Association between Antimyelin Antibodies and Progression to Multiple Sclerosis
Jens Kühle, Christoph Pohl, Matthias Mehling et al. · New England Journal of Medicine · 2007 · 258 citations
Life Sciences, Neurology, Neuroscience +17
Determining the concentration of microorganisms controlled by attributes sampling plans
J.D. Legan, Mark Vandeven, S. Dahms et al. · Food Control · 2001 · 83 citations
Life Sciences, Microbiology, Biological Control +5
Subgroups of the BENEFIT study: Risk of developing MS and treatment effect of interferon beta-1b
CH Polman, Ludwig Kappos, Mark S. Freedman et al. · Journal of Neurology · 2007 · 75 citations · Full text
Pharmacy, Internal Medicine, Pharmacotherapy +13
Magnetic Resonance Imaging Effects of Interferon Beta-1b in the BENEFIT Study
Frederik Barkhof, Chris H. Polman, Ernst‐Wilhelm Radue et al. · Archives of Neurology · 2007 · 49 citations
Medicine, Internal Medicine, Neurology +13
1–5 of 9